Identification of fungicidal 2,6-disubstituted quinolines with activity against candida biofilms

Molecules

Volumn 17, Issue 10, 2012, Pages 12243-12251

  Delattin, Nicolas ^a   Bardiot, Dorothée ^b   Marchand, Arnaud ^b   Chaltin, Patrick ^b,c   De Brucker, Katrijn ^a   Cammue, Bruno P A ^a   Thevissen, Karin ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b CISTIM Leuven Vzw   (Belgium)

^c Centre for Drug Design and Discovery   (Belgium)

Author keywords

2,6 disubstituted quinolines; Antifungal agents; Candida spp.; Reactive oxygen species; Structure activity relationships

Indexed keywords

ANTIFUNGAL AGENT; QUINOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ARTICLE; BIOFILM; CANDIDA; CHEMISTRY; DRUG EFFECT; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; MICROBIAL SENSITIVITY TESTS; QUINOLINES; REACTIVE OXYGEN SPECIES;

EID: 84868131352     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171012243     Document Type: Article

References (22)

1. Marr, K.A. Invasive Candida infections: The changing epidemiology. Oncology (Williston Park) 2004, 18, 9-14.
2. Fanning, S.; Mitchell, A.P. Fungal biofilms. PLoS Pathog. 2012, 8, e1002585.
3. Ramage, G.; Mowat, E.; Jones, B.; Williams, C.; Lopez-Ribot, J. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 2009, 35, 340-355.
4. Kuhn, D.M.; Ghannoum, M.A. Candida biofilms: Antifungal resistance and emerging therapeutic options. Curr. Opin. Investig. Drugs 2004, 5, 186-197.
5. Klepser, M.E. Candida resistance and its clinical relevance. Pharmacotherapy 2006, 26, 68S-75S.
6. Chamilos, G.; Kontoyiannis, D.P. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist. Updat. 2005, 8, 344-358.
7. Odds, F.C. Genomics, molecular targets and the discovery of antifungal drugs. Rev. Iberoam. Micol. 2005, 22, 229-237.
8. Thevissen, K.; Hillaert, U.; Meert, E.M.; Chow, K.K.; Cammue, B.P.; Van Calenbergh, S.; Francois, I.E. Fungicidal activity of truncated analogues of dihydrosphingosine. Bioorg. Med. Chem. Lett. 2008, 18, 3728-3730.
9. Vandenbosch, D.; Braeckmans, K.; Nelis, H.J.; Coenye, T. Fungicidal activity of miconazole against Candida spp. biofilms. J. Antimicrob. Chemother. 2010, 65, 694-700.
10. Al-Dhaheri, R.S.; Douglas, L.J. Apoptosis in Candida biofilms exposed to amphotericin B. J. Med. Microbiol. 2010, 59, 149-157.
11. Lanza, T.J.; Durette, P.L.; Rollins, T.; Siciliano, S.; Cianciarulo, D.N.; Kobayashi, S.V.; Caldwell, C.G.; Springer, M.S.; Hagmann, W.K. Substituted 4, 6-diaminoquinolines as inhibitors of C5a receptor binding. J. Med. Chem. 1992, 35, 252-258.
12. Foley, M.; Tilley, L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol. Ther. 1998, 79, 55-87.
13. Taramelli, D.; Tognazioli, C.; Ravagnani, F.; Leopardi, O.; Giannulis, G.; Boelaert, J.R. Inhibition of intramacrophage growth of Penicillium marneffei by 4-aminoquinolines. Antimicrob. Agents Chemother. 2001, 45, 1450-1455.
14. Ulven, T.; Frimurer, T.M.; Receveur, J.M.; Little, P.B.; Rist, O.; Norregaard, P.K.; Hogberg, T. 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode. J. Med. Chem. 2005, 48, 5684-5697.
15. Thevissen, K.; Marchand, A.; Chaltin, P.; Meert, E.M.; Cammue, B.P. Antifungal carbazoles. Curr. Med. Chem. 2009, 16, 2205-2211.
16. Kobayashi, D.; Kondo, K.; Uehara, N.; Otokozawa, S.; Tsuji, N.; Yagihashi, A.; Watanabe, N. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob. Agents Chemother. 2002, 46, 3113-3117.
17. Thevissen, K.; Ayscough, K.R.; Aerts, A.M.; Du, W.; De Brucker, K.; Meert, E.M.; Ausma, J.; Borgers, M.; Cammue, B.P.; Francois, I.E. Miconazole induces changes in actin cytoskeleton prior to reactive oxygen species induction in yeast. J. Biol. Chem. 2007, 282, 21592-21597.
18. Francois, I.E.; Thevissen, K.; Pellens, K.; Meert, E.M.; Heeres, J.; Freyne, E.; Coesemans, E.; Viellevoye, M.; Deroose, F.; Martinez Gonzalez, S.; et al. Design and synthesis of a series of piperazine-1-carboxamidine derivatives with antifungal activity resulting from accumulation of endogenous reactive oxygen species. ChemMedChem 2009, 4, 1714-1721.
19. Fonzi, W.A.; Irwin, M.Y. Isogenic strain construction and gene mapping in Candida albicans. Genetics 1993, 134, 717-728.
20. Kaur, R.; Ma, B.; Cormack, B.P. A family of glycosylphosphatidylinositol- linked aspartyl proteases is required for virulence of Candida glabrata. Proc. Natl. Acad. Sci. USA 2007, 104, 7628-7633.
21. Aerts, A.M.; Carmona-Gutierrez, D.; Lefevre, S.; Govaert, G.; Francois, I.E.; Madeo, F.; Santos, R.; Cammue, B.P.; Thevissen, K. The antifungal plant defensin RsAFP2 from radish induces apoptosis in a metacaspase independent way in Candida albicans. FEBS Lett. 2009, 583, 2513-2516.
22. Bink, A.; Vandenbosch, D.; Coenye, T.; Nelis, H.; Cammue, B.P.; Thevissen, K. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob. Agents Chemother. 2011, 55, 4033-4037.